Ovarian Cancer Canada

Western Regional Blog – BC, YK, AB, NWT and Nunavut

AACR: Antibody-Drug Conjugate Shows Promise in Platinum-Resistant Ovarian Cancer

“A novel therapy has shown activity in treatment of difficult-to-treat, advanced, platinum-resistant ovarian cancer. The drug, DMUC5754A (Genentech), is part of a new class of drugs called antibody-drug conjugates.“(Phase 1)  … Continue reading

April 29, 2013

Catheters and Ports in Cancer Treatment

This section has been reviewed and approved by the Cancer.Net Editorial Board, 2/2013 http://www.cancer.net/all-about-cancer/cancernet-feature-articles/cancer-basics/catheters-and-ports-cancer-treatment?et_cid=31423988&et_rid=463565042&linkid=Read+about  During cancer treatment, your health care team often needs access to your veins to give you … Continue reading

April 29, 2013

Join a Support Group from Your Computer

Cancer Chat Canada has organized a new professionally-led online support group specifically for ovarian cancer survivors. Every week you’ll log in to a secure site where you’ll “talk” to the professional leading … Continue reading

April 29, 2013

Shelley Janze: Why I Volunteer

Shelley Janze and her mother, Josephine. This year, Shelley is Co-Chair, Sponsorship and Recruitment, of the Vancouver Walk of Hope. I could give several valid reasons for volunteering – giving back … Continue reading

April 25, 2013

Can Inspire Health Help Someone You Know?

Do you know someone with a cancer diagnosis who lives in a remote or rural part of BC?  We are excited to let you know about the InspireLIFE BC pilot … Continue reading

April 25, 2013

Helena Tse: Constructing a link between Ovarian Cancer Canada and her high school

Helena Tse presents Ovarian Cancer: Knowledge is Power awareness program to fellow students. I am Helena Tse, a grade 12 student from Burnaby, British Columbia. My cousin, who is one year … Continue reading

April 24, 2013

Endometriosis-associated ovarian cancers: Pathogenesis and consequences on daily practice

“Recent findings suggest an association between endometriosis and the entire type 1 ovarian tumors group including clear-cell, endometrioid and low-grade serous carcinomas. However, current evidence is lacking to draw definitive … Continue reading

April 20, 2013

Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian Cancer

“PLD plays an important role in the management of ovarian cancer. It represents the standard therapy in platinum-resistant recurrence and one of the standard options in platinum-sensitive patients. Between the … Continue reading

April 20, 2013

What is Polycystic Ovary Syndrome (PCOS)?

Polycystic Ovary Syndrome (PCOS), sometimes called Polycystic Ovarian Disease, is a hormonal disorder that affects between 6 to 10% of women. Symptoms often start once the menstrual cycle begins but … Continue reading

April 20, 2013

Complementary and Alternative Therapies

CAMEO

Research in BC

The Injustices of Ovarian Cancer

Ovarian Cancer Canada